Specialty pharmaceutical company

Providing solutions to unmet medical needs.

Shield Therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late‑stage, hospital‑focused pharmaceuticals which address areas of unmet medical need.

Find out more

Our Products

A treatment for iron deficiency anaemia

Our lead product, Feraccru®, is a novel oral treatment for iron deficiency anaemia (IDA) which, following receipt of marketing authorisation in early 2016, is now commercially available for use initially in patients with inflammatory bowel disease
associated IDA.

Find out more

PM Society Awards Gold winner for Events & Exhibitions

Sponsors of the Primary Care Society of Gastroenterology

London, UK

Bentinck House
3-8 Bolsover Street
London, W1W 6AB

t+44 (0) 207 186 8500


Newcastle, UK

Northern Design Centre
Baltic Business Quarter
Gateshead Quays, NE8 3DF

t+44 (0) 191 511 8500


Wollerau, Switzerland

Shield Therapeutics
c/o Shield Holdings AG
Sihleggstrasse 23, 8832 Wollerau

t+41 (0) 435 080 781